Fibrin stabilization (factor XIII), fibrin structure and thrombosis

被引：35
作者：
Bereczky, Z
Katona, É
Muszbek, L
机构：
[1] Univ Debrecen, Med & Hlth Sci Ctr, Clin Res Ctr, Hungarian Acad Sci, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Med & Hlth Sci Ctr, Thrombosis Res Grp, Hungarian Acad Sci, H-4012 Debrecen, Hungary
来源：
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 2003年 / 33卷 / 5-6期
关键词：
factor XIII; factor XIII-A Val34Leu polymorphism; fibrinolysis; thrombosis;
D O I：
10.1159/000083841
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Factor XIII (FXIII) is a zymogen that is converted into an active transglutaminase (FXIIIa) by the concerted action of thrombin and Ca2+. Its main task is to crosslink alpha-, and gamma-chains of fibrin and alpha2-plasmin inhibitor to fibrin. By this way FXlIIa strengthens fibrin and protects it from the prompt elimination by fibrinolytic system. The changes of FXIII level in thrombotic diseases are hardly explored and there are contradictory results concerning the protective effect of Val34Leu polymorphism against arterial or venous thrombosis. The results suggest that the thrombo-protective effect of Leu34 allele prevails only in certain genetic and/or environmental constellations. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码：430 / 437
页数：8
相关论文
共 108 条
[81]   Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women [J].
Reiner, AP ;
Frank, MB ;
Schwartz, SM ;
Linenberger, ML ;
Longstreth, WT ;
Teramura, G ;
Rosendaal, F ;
Psaty, BM ;
Siscovick, DS .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (02) :376-382
[82]   Prothrombin G20210A, factor V Leiden, and factor XIII Va134Leu:: Common mutations of blood coagulation factors and deep vein thrombosis in Austria [J].
Renner, W ;
Köppel, H ;
Hoffmann, C ;
Schallmoser, K ;
Stanger, O ;
Toplak, H ;
Wascher, TC ;
Pilger, E .
THROMBOSIS RESEARCH, 2000, 99 (01) :35-39
[83]  
Renner W, 2002, INT ANGIOL, V21, P53
[84]   THROMBIN MODULATES SYNTHESIS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 BY HUMAN PERIPHERAL-BLOOD MONOCYTES [J].
RITCHIE, H ;
JAMIESON, A ;
BOOTH, NA .
BLOOD, 1995, 86 (09) :3428-3435
[85]  
Ritchie H, 1999, THROMB HAEMOSTASIS, V81, P96
[86]   Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction [J].
Roldán, V ;
Corral, J ;
Marín, F ;
Rivera, J ;
Pineda, J ;
González-Conejero, R ;
Sogorb, F ;
Vicente, V .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (10) :1242-1245
[87]  
Roldán V, 2002, THROMB HAEMOSTASIS, V88, P354
[88]   CROSS-LINKING OF ALPHA-2-PLASMIN INHIBITOR TO FIBRIN BY FIBRIN-STABILIZING FACTOR [J].
SAKATA, Y ;
AOKI, N .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (02) :290-297
[89]  
SAKATA Y, 1984, BLOOD, V63, P1393
[90]  
Schröder V, 2000, THROMB HAEMOSTASIS, V84, P1128
234567891011